Company AB Science

AB

FR0010557264

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-06-25 EDT			After hours 13:19:07
0.8580 ^EUR	-1.38%		0.8590	+0.12%

06-18	AB Science Secures US Patent for Prostate Cancer Therapy	MT
06-18	AB Science Secures New U.S. Patent for Masitinib

Business description: AB Science

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 31

Sales by Activity: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Pharmaceuticals	1.61M	958K	970K	1.07M	1.17M

See all business segments

Geographical breakdown of sales: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Europe	-	-	-	-	955K
outside Europe	-	-	-	-	219K

See all geographic segments

Executive Committee: AB Science

Manager	Title	Age	Since
Alain Moussy CEO	Chief Executive Officer	-	2001-07-10
Laurent Guy DFI	Director of Finance/CFO	-	2009-11-19
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	2018-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

See AB SCIENCE governance

Composition of the Board of Directors: AB Science

Director	Title	Age	Since
Alain Moussy CHM	Chairman	-	2001-07-10
Patrick Moussy BRD	Director/Board Member	-	2011-09-19
Cécile de Guillebon BRD	Director/Board Member	64	2021-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	68	2021-06-26
Guillemette Latscha BRD	Director/Board Member	-	2021-06-26
Renaud Sassi BRD	Director/Board Member	-	2021-06-26

Composition of the Board of Directors

Shareholders: AB Science

Name	Stocks	%	Valuation
Jean-Claude Marian 10.41 %	6,888,610	10.41 %	8 M €
UBS Wealth Management SGIIC SA 0.004684 %	3,100	0.004684 %	3 487 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 5.198 %	85,471	5.198 %	33 313 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 4.167 %	64,103	4.167 %	20 496 €

List of AB SCIENCE shareholders

Company details: AB Science

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AB SCIENCE	-1.38%	+0.82%	-32.01%	-78.87%	75.63M
MERCK & CO., INC.	+2.63%	+8.54%	+55.14%	+9.30%	298B
MERCK KGAA	+4.93%	+10.48%	+33.21%	-3.67%	69.19B
HALOZYME THERAPEUTICS, INC.	+1.76%	+5.70%	+38.49%	+107.98%	8.44B
KYOWA KIRIN CO., LTD.	+0.20%	+4.60%	+3.04%	-6.96%	8.27B
SK BIOPHARMACEUTICALS CO., LTD.	+2.31%	-1.99%	-4.63%	+4.85%	4.4B
BETTA PHARMACEUTICALS CO., LTD.	+4.94%	+21.87%	+11.93%	+29.39%	3.64B
YUHAN CORPORATION	-1.38%	-9.86%	-30.57%	+29.30%	3.5B
SUPERNUS PHARMACEUTICALS, INC.	-0.88%	+0.63%	+42.96%	+46.96%	2.62B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+2.36%	+9.75%	+13.51%	-20.42%	2.07B
Average	+1.52%	+3.46%	+13.11%	+11.79%	40.01B
Weighted average by Cap.	+2.87%	+3.98%	+47.81%	+9.19%